A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Usodiol

Bile Acid class · 0 generic manufacturers · 0 ANDAs filed at FDA.

First FDA approval2020-07-01
Generic availableNo (brand-only)
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
/unit
0 NDCs benchmarked, lowest of all strengths.
Average NADAC
Across all dosage forms in distribution.
Highest NADAC
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema7 entries indexed · 4 visible
What is Usodiol used for?

Usodiol is a Bile Acid medication tracked in Medicare Part D.

Is there a generic for Usodiol?

No. Usodiol is brand-only with no generic equivalents currently in market.

How much does my plan pay for Usodiol?

NADAC pricing data not currently available for this drug.

Is Usodiol on the FDA shortage list?

No. Usodiol is not currently on the FDA Drug Shortage Database.

3 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Bile Acid3 alternatives in D1
01
Chenodiol
Brand: CTEXLI
Lowest NADAC
1Generic mfrs
$31.2MCY24 Part D spend
Compare →
02
Cholic Acid
Brand: CHOLBAM
Lowest NADAC
0Generic mfrs
$9.5MCY24 Part D spend
Compare →
03
Ursodiol
Brand: Urso 250
$0.412Lowest NADAC
13Generic mfrs
$116.3MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.